A recent study reported that in chronic hepatitis patients with AFP<20 ng/ml, DCP showed a high specificity of 100% in patients who combined with HCC, using a microchip capillary electrophoresis and liquid-phase binding assay [24]. This evidence concerns the gene AFP and hepatocellular carcinoma.